Publications | Flatiron Health | HEOR / RWE

Browse every publication tagged HEOR / RWE

November 2026
Treatment patterns and outcomes post-CAR T failure in LBCL: the "what comes next" question
November 2026
Real-world comparison of biologic features, treatment patterns, and clinical outcomes between younger (≤55 years) and older (>55 years) patients with CLL receiving frontline targeted therapy
November 2026
Association of lymphopenia with outcomes in diffuse large B cell lymphoma in the era of T-cell directed therapies
November 2026
Frontline treatment and consolidation strategies and associated outcomes in primary central nervous system lymphoma: a large US real-world study
November 2026
Real-world safety and effectiveness of elranatamab in multiple myeloma, including in late-line and BCMA-exposed patients
November 2026
Real-world treatment patterns and outcomes over time of patients with high-grade B-cell lymphoma in a large US oncology network
November 2026
Unmasking hidden risk: clinical and real-world factors associated with functional high-risk multiple myeloma and their impact on treatment and outcomes — a real-world evidence study
November 2026
Beyond treatment patterns: clinician-documented decision-making following dual BTK inhibitors and BCL2 inhibitor exposure in chronic lymphocytic leukemia